The administration of pirfenidone modifies the expression of JMJD2B in a murine model of NASH
Introduction and Objectives: This study aimed to evaluate how the administration of pirfenidone modifies the expression of JMJD2B in a murine model of NASH. Materials and methods: 4–5-week-old male C57BL/6J mice fed a high-fat diet for 16 weeks. Follow-up was done at 4, 8, 12 and 16 weeks. Serum glu...
Main Authors: | JS Rodriguez Sanabria, J García Bañuelos, R Escutia Gutiérrez, CA Monraz Méndez, A Santos, J Armendáriz-Borunda, AS Sandoval Rodríguez |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-12-01
|
Series: | Annals of Hepatology |
Online Access: | http://www.sciencedirect.com/science/article/pii/S166526812200196X |
Similar Items
-
Moringa oleifera decreases biomarkers of oxidative stress in a murine NASH model
by: A Monraz-Méndez, et al.
Published: (2022-12-01) -
Pirfenidone ameliorates MAFLD by improving insulin sensitivity and reducing epididymal fat
by: J. Gutiérrez-Cuevas, et al.
Published: (2022-12-01) -
P- 25 ANTIOXIDANT EFFECT OF MORINGA OLEIFERA IN A MURINE MODEL OF NONALCOHOLIC STEATOHEPATITIS
by: Alejandra Monraz-Méndez, et al.
Published: (2023-03-01) -
Pirfenidone Is an Agonistic Ligand for PPARα and Improves NASH by Activation of SIRT1/LKB1/pAMPK
by: Ana Sandoval‐Rodriguez, et al.
Published: (2020-03-01) -
Pirfenidone decreases insulin, glucagon, leptin, plasminogen activator inhibitor 1, preventing nonalcoholic steatohepatitis and myocarditis in an obesity moldel
by: Daniel López-Cifuentes, et al.
Published: (2024-02-01)